Progressive multifocal leukoencephalopathy
Related Experiment Video
Updated: Sep 4, 2026
06:24
Mouse Models of Periventricular Leukomalacia
Published on: May 18, 2010
Neurologic Clinics
|May 1, 1984
Abstract:
PML is a progressive opportunistic infection of the CNS caused by a commonly occurring virus that may become manifest in the context of reduced host resistance in persons of any age. The authors review the disease and its causes, including a discussion of treatment attempts and differential diagnoses.
Insights
Progressive multifocal leukoencephalopathy (PML) is a serious opportunistic central nervous system (CNS) infection. This review covers its causes, treatment, and differential diagnoses for patients with reduced immunity.
Area of Science:
- Neuroscience
- Infectious Diseases
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare but severe opportunistic infection affecting the central nervous system (CNS).
- It is caused by the JC virus, a common polyomavirus, typically occurring in immunocompromised individuals.
- PML can lead to significant neurological disability and is often fatal.
Purpose of the Study:
- To provide a comprehensive review of Progressive multifocal leukoencephalopathy (PML).
- To discuss the underlying causes and pathogenesis of PML.
- To explore current treatment strategies and differential diagnoses for PML.
Main Methods:
- Literature review of existing studies on PML.
- Analysis of clinical manifestations and diagnostic criteria.
- Synthesis of information on therapeutic interventions and outcomes.
Main Results:
- PML is characterized by demyelination in the CNS due to JC virus reactivation.
- Risk factors include conditions leading to reduced host resistance, such as HIV/AIDS, certain immunosuppressive therapies, and hematologic malignancies.
- Early diagnosis and prompt management are crucial for improving patient outcomes.
Conclusions:
- PML represents a significant challenge in neuroimmunology and infectious diseases.
- Understanding the viral causes and host immune status is key to managing PML.
- Further research into effective treatments and preventative strategies is warranted.
Related Concept Videos
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...